BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Demyelinating

Below is an extended Demyelinating research listing. Click here to return to the Demyelinating main in depth entry.

Recent Publications on Demyelinating:

Combination therapy of lovastatin and rolipram provides neuroprotection and promotes neurorepair in inflammatory demyelination model of multiple sclerosis.
Drug combination therapies for central nervous system (CNS) demyelinating...
Direct Link
23rd August, 2008
Department of Pediatrics, Medical University of South Carolina,
Probing the influence of myelin and glia on the tensile properties of the spinal cord.
Although glia have been historically classified as the structurally...
Direct Link
23rd August, 2008
Department of Biomedical Engineering, Rutgers, The State University of New
Current concepts in the diagnosis of transverse myelopathies.
The clinical symptoms and MRI characteristics of transverse myelopathy...
Direct Link
23rd August, 2008
Referral Center for Demyelinating diseases of the Central Nervous System,
Glial reactions and degeneration of myelinated processes in spinal cord gray matter in chronic experimental autoimmune encephalomyelitis.
Multiple sclerosis and experimental autoimmune encephalomyelitis (EAE)...
Direct Link
23rd August, 2008
Department of Neurology, David Geffen School of Medicine at UCLA, Charles
The role of IL-12 and TNF-alpha in AIDP and AMAN.
Background: Acute inflammatory demyelinating polyradiculoneuropathy (AIDP)...
Direct Link
23rd August, 2008
Department of Neurology, The First Hospital, Jilin University, Changchun,
Charcot-Marie-Tooth type X: unusual phenotype of a novel CX32 mutation.
Background: X-linked Charcot-Marie-Tooth disease (CMTX), caused by...
Direct Link
23rd August, 2008
Department of Neurosciences, Psychiatry and Anaesthesiology, AOU 'G.
Recommendations on diagnostic strategies for chronic inflammatory demyelinating polyradiculoneuropathy.
BACKGROUND: Chronic inflammatory demyelinating polyradiculoneuropathy...
Direct Link
22nd August, 2008
Department of Neurology, University Hospital, 2 Av. Martin Luther King,
Intrathecal anti-alphaB-crystallin IgG antibody responses: potential inflammatory markers in Guillain-Barre syndrome.
OBJECTIVE: alphaB-crystallin (alphaBC), a small stress protein with...
Direct Link
21st August, 2008
Clinical Department of Neurology, Innsbruck Medical University,
Glial precursor cell transplantation therapy for neurotrauma and multiple sclerosis.
Traumatic injury to the brain or spinal cord and multiple sclerosis (MS)...
Direct Link
19th August, 2008
Krembil Neuroscience Centre, Toronto Western Research Institute, 399
The demyelinating diseases.
Traumatic injury to the brain or spinal cord and multiple sclerosis (MS)...
Direct Link
16th August, 2008
Refferal Center for Demyelinating Diseases of the Central Nervous System,
Disseminated encephalomyelitis in adults.
Disseminated encephalomyelitis (DEM) is an inflammatory demyelinating...
Direct Link
16th August, 2008
Department of Neurology, Reffered Center for Demyelinating Diseases of
NMO-IgG positive neuromyelitis optica in a patient with myasthenia gravis but no thymectomy.
Here we report on a 44-year old woman presenting with both myasthenia...
Direct Link
16th August, 2008
Division of Neurology, Department of Internal Medicine, Universidade
Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study.
BACKGROUND: Repeated subcutaneous injections of a monoclonal antibody...
Direct Link
16th August, 2008
Department of Neurology, Holtom-Garrett Programme in Neuroimmunology,
Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial.
OBJECTIVE: To determine the long-term effect of adalimumab on patients...
Direct Link
15th August, 2008
Leiden University Medical Center.
Compound heterozygous deletions of PMP22 causing severe Charcot-Marie-Tooth disease of the Dejerine-Sottas disease phenotype.
Dejerine-Sottas disease (DSD) is a particular phenotype of the...
Direct Link
14th August, 2008
F. Clarke Fraser Clinical Genetics Unit, Division of Medical Genetics,
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional